Aurinia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$16.67

+0.06 (+0.36%)

As of Sep 22, 1:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +143.8% upside

Low Target $34.07

Average Target $40.64

High Target $61.77

Current Price $16.67

Current
$16.67

Target
$40.64

$34.07 $40.64 avg $61.77

Scenario Analysis

Bear Case

$34.07

104.4%

Low target

Base Case

$40.64

+143.8%

Avg target

Bull Case

$61.77

+270.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$19.25

-13.4% from high

52-Week Low

$10.34

+61.2% from low

Target vs 52W High

$40.64

+111.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%